Phase II trial of chemoradiotherapy (50.4Gy, modified 5-FU+CDDP) for clinical Stage II/III esophageal carcinoma
Phase 2
- Conditions
- Esophageal cancer
- Registration Number
- JPRN-UMIN000000856
- Lead Sponsor
- ational Cancer Center Hospital, Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. Fistula 2. Sever complications 3. Active infection 4. Past history of radiotherapy of chest 5. Intersitial pneumonia or fibrosis 6. Active double cancer 7. Pregnancy 8. Mental illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1-year survival rate
- Secondary Outcome Measures
Name Time Method 3-year survival rate, progression free survival, CR rate, toxicity rate, late toxicity rate